Variant position: 804 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1466 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human APGLPGIAGPRGSPGERGET GPPGPAGFPGAPGQNGEPGGK
Mouse SPGLPGIAGPRGGPGERGEH GPPGPAGFPGAPGQNGEPGAK
Rat APGLPGIAGPRGGPGERGEH GPPGPAGFPGAPGQNGEPGAK
Bovine APGVPGIAGPRGGPGERGEQ GPPGPAGFPGAPGQNGEPGAK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
154 – 1221 Collagen alpha-1(III) chain
168 – 1196 Triple-helical region
785 – 785 4-hydroxyproline
788 – 788 4-hydroxyproline
797 – 797 4-hydroxyproline
806 – 806 4-hydroxyproline
812 – 812 4-hydroxyproline
815 – 815 4-hydroxyproline
821 – 821 4-hydroxyproline
A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637-to-serine substitution in type III collagen.
Narcisi P.; Richards A.J.; Ferguson S.D.; Pope F.M.;
Hum. Mol. Genet. 3:1617-1620(1994)
Cited for: VARIANT EDSVASC SER-804;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.